Atherosclerosis/plaque imaging with CMR: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
(One intermediate revision by one other user not shown)
Line 68: Line 68:




[[Category:Cardiology]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
{{mdr}}
{{mdr}}
[[CME Category::Cardiology]]
[[Category:Cardiology]]

Latest revision as of 15:01, 27 February 2018

WikiDoc Resources for Atherosclerosis/plaque imaging with CMR

Articles

Most recent articles on Atherosclerosis/plaque imaging with CMR

Most cited articles on Atherosclerosis/plaque imaging with CMR

Review articles on Atherosclerosis/plaque imaging with CMR

Articles on Atherosclerosis/plaque imaging with CMR in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atherosclerosis/plaque imaging with CMR

Images of Atherosclerosis/plaque imaging with CMR

Photos of Atherosclerosis/plaque imaging with CMR

Podcasts & MP3s on Atherosclerosis/plaque imaging with CMR

Videos on Atherosclerosis/plaque imaging with CMR

Evidence Based Medicine

Cochrane Collaboration on Atherosclerosis/plaque imaging with CMR

Bandolier on Atherosclerosis/plaque imaging with CMR

TRIP on Atherosclerosis/plaque imaging with CMR

Clinical Trials

Ongoing Trials on Atherosclerosis/plaque imaging with CMR at Clinical Trials.gov

Trial results on Atherosclerosis/plaque imaging with CMR

Clinical Trials on Atherosclerosis/plaque imaging with CMR at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atherosclerosis/plaque imaging with CMR

NICE Guidance on Atherosclerosis/plaque imaging with CMR

NHS PRODIGY Guidance

FDA on Atherosclerosis/plaque imaging with CMR

CDC on Atherosclerosis/plaque imaging with CMR

Books

Books on Atherosclerosis/plaque imaging with CMR

News

Atherosclerosis/plaque imaging with CMR in the news

Be alerted to news on Atherosclerosis/plaque imaging with CMR

News trends on Atherosclerosis/plaque imaging with CMR

Commentary

Blogs on Atherosclerosis/plaque imaging with CMR

Definitions

Definitions of Atherosclerosis/plaque imaging with CMR

Patient Resources / Community

Patient resources on Atherosclerosis/plaque imaging with CMR

Discussion groups on Atherosclerosis/plaque imaging with CMR

Patient Handouts on Atherosclerosis/plaque imaging with CMR

Directions to Hospitals Treating Atherosclerosis/plaque imaging with CMR

Risk calculators and risk factors for Atherosclerosis/plaque imaging with CMR

Healthcare Provider Resources

Symptoms of Atherosclerosis/plaque imaging with CMR

Causes & Risk Factors for Atherosclerosis/plaque imaging with CMR

Diagnostic studies for Atherosclerosis/plaque imaging with CMR

Treatment of Atherosclerosis/plaque imaging with CMR

Continuing Medical Education (CME)

CME Programs on Atherosclerosis/plaque imaging with CMR

International

Atherosclerosis/plaque imaging with CMR en Espanol

Atherosclerosis/plaque imaging with CMR en Francais

Business

Atherosclerosis/plaque imaging with CMR in the Marketplace

Patents on Atherosclerosis/plaque imaging with CMR

Experimental / Informatics

List of terms related to Atherosclerosis/plaque imaging with CMR

Editors-in-Chief: Eric A. Osborn, M.D., Ph.D. [1] and Eli V. Gelfand, M.D. [2] (Beth Israel Deaconess Medical Center, Harvard Medical School)


Introduction

Cardiovascular magnetic resonance (CMR) plaque imaging allows characterization of the biology of atherosclerotic lesions. Using multiple imaging sequences targeted to specific plaque constituents, the underlying composition of the plaque is determined including markers of remodeling and inflammation that are clinically relevant surrogates of plaque stability. With this technique, ‘vulnerable’ plaques prone to rupture are identified that predispose patients to acute coronary syndromes and stroke.

Pulse sequences

  • Bright blood sequences are used for angiography
  • Black blood sequences are used for vessel wall imaging

Techniques

  • Identification of plaque components requires a multi-contrast approach with three weightings (T1, PD, T2) in black blood imaging and complementary bright blood imaging
    • T1- and PD-weightings provide strong signal from the fibrous matrix and lipid core
    • T2 aides in discriminating certain plaque tissue types but has a lower SNR and poor wall delineation
  • Dynamic contrast enhancement (CE) with gadolinium allows evaluation of neovascularization and the time-dependent diffusion of contrast into the extracellular space
  • Resolution: 0.4-0.6mm in-plane, 2-3mm slice thickness

Characterization

Size

  • Thickness
  • Eccentricity
  • Distribution
  • Proximity of the necrotic core to the lumen

Fig. Simple plaque [[Image: ]] Fig. Complex plaque [[Image: ]]

Composition

  • Lipid-rich / necrotic core

Fig. Lipid-rich / necrotic core [[Image: ]]

  • Fibrous cap

Fig. Dense fibrous cap [[Image: ]] Fig. Loose fibrous cap [[Image: ]]

  • Calcifications
  • Hemorrhage

Fig. Fresh hemorrhage [[Image: ]] Fig. Old hemorrhage [[Image: ]]

Biological activity

  • Cellular markers of plaque generation

Fig. [[Image: ]]

  • Inflammatory reaction at the fibrous cap

Fig. [[Image: ]]

Validation

Trials

Further online resources

References

<biblio> #ref1 pmid=16986119 </biblio>


Template:WikiDoc Sources Template:Mdr CME Category::Cardiology